본문 바로가기
KERD
논문KCI 등재

Short-term Safety of Dimethyl Fumarate for Psoriasis in Korea

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류피부과학

참고문헌 (10)

  1. Pellacani G, "Efficacy and safety of dimethyl fumarate in patients with moderate-to-severe plaque psoriasis : DIMESKIN-2, a multicentre single-arm phase IIIb study", J Clin Med, 11, pp.4778~ (2022)
  2. Corazza M, "Dimethyl fumarate treatment for psoriasis in a real-life setting : a multicentric retrospective study", Dermatol Ther, 34, pp.e15066~ (2021)
  3. Mrowietz U, "Efficacy and safety of LAS41008(dimethyl fumarate)in adults with moderate-to-severe chronic plaque psoriasis : a randomized, double-blind, Fumaderm®-and placebo-controlled trial(BRIDGE)", Br J Dermatol, 176, pp.615~623 (2017)
  4. Malara G, "Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis", Drugs Context, 10, pp.2020~2012 (2021)
  5. Fahrbach K, "Short-term efficacy of biologic therapies in moderate-to-severe plaque psoriasis : a systematic literature review and an enhanced multinomial network meta-analysis", Dermatol Ther(Heidelb), 11, pp.1965~1998 (2021)
  6. Dickel H, "Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients : a single-centre, retrospective, observational study", J Eur Acad Dermatol Venereol, 32, pp.1710~1727 (2018)
  7. Mrowietz U, "Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis : a European expert consensus", J Eur Acad Dermatol Venereol, 32(Suppl 3), pp.3~14 (2018)
  8. Pezzolo E, "Efficacy and safety of dimethyl fumarate in comparison with conventional therapy for psoriasis : an Italian real-world clinical experience", J Eur Acad Dermatol Venereol, 36, pp.e534~e537 (2022)
  9. Lucchetta RC, "Disease-modifying therapies for relapsing-remitting multiple sclerosis : a network meta-analysis", CNS Drugs, 32, pp.813~826 (2018)
  10. Aubets J, "No evidence for interactions of dimethylfumarate(DMF)and its main metabolite monomethylfumarate(MMF)with human cytochrome P450(CYP)enzymes and the P-glycoprotein(P-gp)drug transporter", Pharmacol Res Perspect, 7, pp.e00540~ (2019)

관련 논문AI추천

Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center권수현, 이은소대한피부과학회 · Annals of Dermatology2020 · 제32권 제3호Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)고주연, 김광중, 김동현, 김병수, 김일환, 김진주, 박해진, 손상욱, 안지영, 이운하, 이은소, 정기현, Javed Rashid대한피부과학회 · Annals of Dermatology2023 · 제35권 제2호Immune Parameters of Korean Patients with Psoriasis Treated with Low-Dose Cyclosporine김낙인, 신민경, 신은재, 최정휘대한피부과학회 · Annals of Dermatology2017 · 제29권 제1호The Clinical Efficacy of Azathioprine in Korean Patients with Atopic Dermatitis신정우, 이광훈, 이혜민대한피부과학회 · Annals of Dermatology2015 · 제27권 제6호Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea고현창, 나찬호, 노주영, 박귀영, 박영립, 박영민, 박창욱, 박천욱, 배유인, 서영준, 손상욱, 안지영, 양준모, 원종현, 유광호, 유박린, 이동훈, 이상은, 이성열, 이승철, 이양원, 이지현, 장용현, 전지현, 정혜정, 조상현, 한태영대한피부과학회 · Annals of Dermatology2022 · 제34권 제2호Comparative Study of Clinical Characteristics according to Therapeutic Efficacy and Drug Survival of Cyclosporine or Methotrexate in Psoriasis Vulgaris권수현, 이은소, 이현수대한피부과학회 · Annals of Dermatology2019 · 제31권 제4호

이 간행물의 다른 논문 (9건)